Stevens L M, Davis P L, Fischer A B. "一种的合成方法" [P]. US Patent, US 11697431 B2, 2016-01-01.
发明人罗永刚,高志强,郑宇鹏. "Method for the Synthesis of 3-Methyl-1-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-1h-imidazol-3-ium iodide" [P]. 中国发明专利, 专利号 CN 111180057 B, 授权公告日 2018-02-24.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2019, 2466, (8), 7880-7906.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2010, 385, (2), 5615-5630.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 3-Methyl-1-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-1h-imidazol-3-ium iodide Using HRMS and NMR". J. Chromatogr. A, 2021, 1197, 5567-5591.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2016, 2404, 4539-4546.